For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune ...
HIV-seq identifies key differences in HIV-infected cells before and after starting antiretroviral therapy to support treatment research.
Russell has a PhD in the history of medicine, violence, and colonialism. His research has explored topics including ethics, science governance, and medical involvement in violent contexts. Russell has ...
It's designed to take the place of complicated, multiple drug regimens that many people with HIV need to follow. And it's ...
Researchers conducted a breakthrough proof-of-concept study that found an HIV-like virus particle that could cease the need for lifelong medications. Researchers in George Mason University's Center ...
A two-dose HIV vaccine generated antibodies against the virus in 35 out of 36 people (97 per cent), with no severe side effects. The early-stage trial was designed to demonstrate safety and a proof-of ...
Long-acting antiviral medications are transforming HIV prevention and care, requiring only minimalistic dosing. But as the ...
Add Yahoo as a preferred source to see more of our stories on Google. Close-up of a gloved hand using tweezers to pull genetic material from a suspended DNA molecule. In an ongoing clinical trial, ...
HIV and hepatitis B virus (HBV) both can be transmitted via blood or bodily fluids, but HBV is about 50 to 100 times more easily acquired. Both HIV and HBV are dangerous viruses, but HBV can be much ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results